LA JOLLA—Tickets are now available for the 29th annual Sinfonía en Salk, an evening where music, science, and philanthropy converge for a spectacular celebration. Set against the backdrop of the Salk Institute’s iconic architecture, this exclusive event will take place on Saturday, August 16, 2025, and feature the San Diego Symphony performing with Emmy and Tony Award-winning performer Kristin Chenoweth.
Guests will experience the elegance of the evening with a champagne reception, gourmet dinner, and immersive musical performances, all while contributing to the Salk Institute’s mission to better understand and address some of the world’s most pressing challenges.
This year’s event will feature a special focus on Salk’s Year of Alzheimer’s Disease Research. Guests will learn how Salk scientists are rewriting the narrative on Alzheimer’s, a devastating disease that continues to take a heartbreaking toll on families despite decades of investment. Cross-disciplinary Salk teams are now exploring a largely overlooked driver of the disease—chronic inflammation—rather than focusing solely on traditional hallmarks. By investigating this underlying factor across all brain cell types, not just neurons, they are uncovering new avenues for early detection and treatment.
“Symphony at Salk is more than just a concert—it is an opportunity to celebrate the profound intersection of art and science,” says Amy Jacobs, member of Salk’s Board of Trustees and chair of the Symphony at Salk committee. “As Salk scientists continue to push the boundaries of knowledge in Alzheimer’s and other critical areas of research, events like this help bring those breakthroughs to life.”
Tickets, sponsorships, and advertising opportunities can be purchased at symphony.salk.edu.
Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu
El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.
